Near 30% Weight Loss Seen After Surgery in T1DM Obesity Tags hBA1c Rapid acting short acting Long acting Read more about Near 30% Weight Loss Seen After Surgery in T1DM Obesity
Can a Degludec-Liraglutide Combo Improve HbA1c in Routine Care? Tags FBS Hypoglycemia hBA1c Long acting GLP-1 agonists Read more about Can a Degludec-Liraglutide Combo Improve HbA1c in Routine Care?
Basal-Prandial Insulin Regimen Shows Higher Normal RC Proportion Tags short acting Long acting Read more about Basal-Prandial Insulin Regimen Shows Higher Normal RC Proportion
Delayed Insulin Start Shows Higher Amputation Risk Tags Diabetic Neuropathy Diabetic Nephropathy Retinopathy hBA1c Rapid acting short acting Long acting Read more about Delayed Insulin Start Shows Higher Amputation Risk
Global Survey Reports Perceived Disparities in Diabetes Drug Access Tags Rapid acting short acting Long acting α-Glucosidase inhibitors SGLT-2 Inhibitor Read more about Global Survey Reports Perceived Disparities in Diabetes Drug Access
Randomized Trial Evaluates Open-Source Automated Insulin Delivery Without Meal Announcement in Adults With Type 1 Diabetes Tags Rapid acting short acting Long acting Insulin Pumps Read more about Randomized Trial Evaluates Open-Source Automated Insulin Delivery Without Meal Announcement in Adults With Type 1 Diabetes
EMR-Based Insulin Algorithm Improves Inpatient Glycemia Tags Rapid acting short acting Intermediate acting Long acting Read more about EMR-Based Insulin Algorithm Improves Inpatient Glycemia
Insulin Pen Education Boosts Diabetes Adherence Tags Insulin Pens Long acting Rapid acting short acting Read more about Insulin Pen Education Boosts Diabetes Adherence
STAR Protocol Masters Glycemic Control in ICU Tags FBS Hyperglycemia hyperosmolar state Hyperglycemia hyperosmolar state hBA1c Rapid acting short acting Long acting Read more about STAR Protocol Masters Glycemic Control in ICU
Immune Checkpoint Inhibitors-Induced T1DM Risk Factors Identified in Large Cohort Tags Diabetic Nephropathy Long acting Read more about Immune Checkpoint Inhibitors-Induced T1DM Risk Factors Identified in Large Cohort